Effects of growth hormone on exercise capacity and cardiopulmonary performance in patients with chronic heart failure

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 11, 2007, Pages 4218-4223

  Fazio, Serafino ^a,b   Palmieri, Emiliano A ^a   Affuso, Flora ^a   Cittadini, Antonio ^a   Castellano, Graziella ^a   Russo, Teresa ^a   Ruvolo, Antonio ^a   Napoli, Raffaele ^a   Saccà, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; HUMAN GROWTH HORMONE; PLACEBO; RAMIPRIL;

ADULT; APPARATUS; ARTICLE; CARDIOPULMONARY FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EXERCISE; EXERCISE TEST; FEMALE; HEART FAILURE; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY;

EID: 35948930201     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1189     Document Type: Article

References (40)

1. Saccà L, Fazio S 1996 Cardiac performance: growth hormone enters the race. Nat Med 2:29-31
2. Saccà L 1999 Growth hormone therapy for heart failure: swimming against the stream. J Card Fail 5:269-275
3. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross Jr J 1995 Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 95:619-627
4. Yang R, Bunting S, Gillett N, Clark RG, Jin H 1995 Growth hormone improves cardiac performance in experimental heart failure. Circulation 92:262-267
5. Duerr RL, McKirnan D, Gim RD, Clark RG, Chien KR, Ross Jr J 1996 Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 93:2188-2196
6. Cittadini A, Grossman JD, Napoli R, Katz SE, Stromer H, Smith RJ, Clark R, Morgan JP, Douglas PS 1997 Growth hormone attenuates early ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol 29:1109-1116
7. Shen YT, Woltmann RF, Appleby S, Prahalada S, Krause SM, Kivilghn SD, Johnson RG, Siegl PK, Lynch JJ 1998 Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failure. Am J Physiol 274:H456-H466
8. Tajima M, Weinberg EO, Bartunek J, Jin H, Yang R, Paoni NF, Lorell BH 1999 Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation 99:127-134
9. Houck WV, Pan LC, Kribbs SB, Clair MJ, McDaniel GM, Krombach RS, Merritt WM, Pirie C, Iannini JP, Mukherjee R, Spinale FG 1999 Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure. Circulation 100:2003-2009
10. Omerovic E, Bollano E, Mobini R, Kujacic V, Madhu B, Soussi B, Fu M, Hjalmarson A, Waagstein F, Isgaard J 2000 Growth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts. Endocrinology 141:4592-4599
11. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, Sacca L 1996 A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 334:809-814
12. Genth-Zotz S, Zotz R, Giel S, Voigtlander T, Meyer J, Darius H 1999 Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation 99:18-21
13. Spallarossa P, Rossettin P, Minuto F, Caruso D, Cordera R, Battistini M, Barreca A, Masperone MA, Brunelli C 1999 Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease. Am J Cardiol 84:430-433
14. Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hanlein D, Willenbrock R, Anker SD, Poole-Wilson PA, Ranke MB, Dietz R 1998 Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351:1233-1237
15. Isgaard J, Bergh CH, Caidahl K, Lomsky M, Hjalmarson A, Bengtsson B-A 1998 A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J 19:1704-1711
16. Acevedo M, Corbalan R, Chamorro G, Jalil J, Nazzal C, Campusano C, Castro P 2003 Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status. Int J Cardiol 87:185-191
17. Adamopoulos S, Parissis JT, Paraskevaidis I, Karatzas D, Livanis E, Georgiadis M, Karavolias G, Mitropoulos D, Degiannis D, Kremastinos DT 2003 Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J 24:2186-2196
18. Jose VJ, Zechariah TU, George P, Jonathan V 1999 Growth hormone therapy in patients with dilated cardiomyopathy: preliminary observations of a pilot study. Indian Heart J 51:183-185
19. Perrot A, Ranke MB, Dietz R, Osterziel KJ 2001 Growth hormone treatment in dilated cardiomyopathy. J Card Surg 16:127-131
20. Smit JW, Janssen YJ, Lamb HJ, van der Wall EE, Stokkel MP, Viergever E, Biermasz NR, Bax JJ, Vliegen HW, de Roos A, Romijn JA, Roelfsema F 2001 Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab 86:4638-4643
21. Le Corvoisier P, Hittinger L, Chanson P, Montagne O, Macquin-Mavier I, Maison P 2007 Cardiac effects of growth hormone treatment in chronic heart failure: a meta-analysis. J Clin Endocrinol Metab 92:180-185
22. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB 1998 Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 129:286-293
23. Lauer MS, Okin PM, Larson MG, Evans JC, Levy D 1996 Impaired heart rate response to graded exercise. Prognostic implications for chronotropic incompetence in the Framingham Heart Study. Circulation 93:1520-1526
24. Miller WF, Scacci R, Gast LR 1987 Laboratory evaluation of pulmonary function. Philadelphia: Lippincott; 300
25. Beaver WL, Wasserman K, Whipp BJ 1986 A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 60:2020-2027
26. Whipp BJ, Ward SA, Wasserman K 1984 Ventilatory responses to exercise and their control in man. Am Rev Respir Dis 129:S17-S20
27. Wilkoff BL, Miller RE 1992 Exercise testing for chronotropic assessment. Cardiol Clin 10:705-717
28. Wassermann K, Hansen JE, Sue DY, Casaburi R, Whipp BJ 1999 Principles of exercise testing and interpretation. 3rd ed. Baltimore: Lippincott, Williams, Wilkins; 148
29. Sahn DJ, DeMaria A, Kisslo J, Weyman A 1978 Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083
30. Fazio S, Cittadini A, Sabatini D, Merola B, Colao AM, Biondi B, Lombardi G, Saccà L 1993 Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. Eur Heart J 14:26-33
31. Napoli R, Guardasole V, Matarazzo M, Palmieri EA, Oliviero U, Fazio S, Saccà L 2002 Growth hormone corrects endothelial dysfunction in patients with chronic heart failure. J Am Coll Cardiol 39:90-95
32. Wasserman K, Zhang YY, Gitt A, Belardinelli R, Koike A, Lubarsky L, Agostoni PG 1997 Lung function and exercise gas exchange in chronic heart failure. Circulation 96:2221-2227
33. Anker SD, Volterrani M, Pflaum CD, Strasburger CJ, Osterziel KJ, Doehner W, Ranke MB, Poole-Wilson PA, Giustina A, Dietz R, Coats AJ 2001 Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 38:433-452
34. Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pitrosante M, Lombardi G, Bellastella A, Carella C, Colao A 2000 Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injection. J Clin Endocrinol Metab 85:3720-3725
35. Isgaard J, Carlsson L, Isaksson OGP, Jansson J-O 1988 Pulsatile intravenous growth hormone (GH) infusion to hypophysectomised rats increases insulin-like growth factor I messenger ribonucleic acid more effectively than continuous GH infusion. Endocrinology 123:2605-2610
36. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329
37. Kleber FX, Wensel R, Felix SB, Reindl I, Baumann G 1996 Acetylcholine causes dose-dependent increase in pulmonary flow in patients with chronic heart failure and elevated pulmonary vascular resistance. Basic Res Cardiol 91:401-405
38. Capaldo B, Lembo G, Rendina V, Vigorito C, Guida R, Cuocolo A, Fazio S, Sacca L 1998 Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy. Eur Heart J 19:623-627
39. Farquharson CAJ, Struthers AD 2000 Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation 101:594-597
40. Wang W 1994 Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension 24:571-575